Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 1.000 | moderate | 0.937 | 13 | 8 | 1998 | 2019 | ||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
disease | 0.700 | None | 0.950 | 16 | 18 | 2006 | 2020 | ||||||||
|
autophagy related 16 like 1 | 0.543 | 0.769 | 0.96 |
|
disease | 0.700 | None | 0.953 | 11 | 9 | 2001 | 2020 | ||||||||
|
immunity related GTPase M | 0.617 | 0.538 |
|
disease | 0.700 | None | 0.939 | 6 | 5 | 2007 | 2020 | |||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.700 | None | 0.880 | 1 | 1 | 1994 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.700 | strong | 0.962 | 1 | 1 | 1996 | 2020 | ||||||||
|
tyrosine kinase 2 | 0.505 | 0.769 | 4.5E-08 |
|
disease | 0.620 | None | 0.800 | 3 | 2 | 2010 | 2016 | ||||||||
|
fucosyltransferase 2 | 0.552 | 0.731 | 5.3E-14 |
|
disease | 0.500 | None | 1.000 | 6 | 4 | 2010 | 2020 | ||||||||
|
leucine rich repeat kinase 2 | 0.510 | 0.808 | 2.6E-30 |
|
disease | 0.500 | None | 1.000 | 5 | 5 | 2008 | 2019 | ||||||||
|
macrophage stimulating 1 | 0.465 | 0.885 | 4.8E-19 |
|
disease | 0.500 | None | 1.000 | 5 | 1 | 2008 | 2018 | ||||||||
|
protein tyrosine phosphatase non-receptor type 2 | 0.538 | 0.692 | 1.00 |
|
disease | 0.500 | None | 1.000 | 5 | 5 | 2007 | 2018 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.500 | strong | 0.969 | 5 | 4 | 2008 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.500 | None | 0.940 | 1 | 1 | 2004 | 2019 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.460 | None | 1.000 | 5 | 6 | 1999 | 2018 | ||||||||
|
neutrophil cytosolic factor 4 | 0.644 | 0.615 | 9.0E-08 |
|
disease | 0.450 | None | 0.714 | 1 | 1 | 2007 | 2017 | ||||||||
|
BTB domain and CNC homolog 2 | 0.539 | 0.731 | 1.00 |
|
disease | 0.440 | None | 1.000 | 4 | 2 | 2010 | 2018 | ||||||||
|
SMAD family member 3 | 0.415 | 0.923 | 0.80 |
|
disease | 0.430 | None | 1.000 | 5 | 3 | 2010 | 2019 | ||||||||
|
endoplasmic reticulum aminopeptidase 2 | 0.615 | 0.577 | 1.0E-28 |
|
disease | 0.420 | None | 1.000 | 5 | 4 | 2010 | 2017 | ||||||||
|
DENN domain containing 1B | 0.716 | 0.308 | 0.20 |
|
disease | 0.400 | None | 1.000 | 4 | 4 | 2010 | 2017 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
disease | 0.400 | None | 1.000 | 2 | 2 | 2010 | 2016 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.200 | None | 0.800 | 4 | 1 | 2005 | 2018 | ||||||||
|
TNF superfamily member 15 | 0.531 | 0.692 | 2.8E-03 |
|
disease | 0.200 | None | 0.979 | 4 | 5 | 2003 | 2019 | ||||||||
|
TNF receptor superfamily member 1A | 0.409 | 0.923 | 0.99 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 2002 | 2019 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1998 | 2018 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
disease | 0.190 | None | 0.900 | 1 | 1 | 1998 | 2017 |